SVRA
Savara Inc
Savara Inc (SVRA) has 2 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 24, 2026.
Insiders have net sold $2.2M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Matthew Pauls
- Employees:59
- HQ:Langhorne, TX, US
- IPO:2017-04-28
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.2M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$1.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Lowrance David LFirst filing | Chief Financial Officer | Sale | 394,528 | $2.2M | Jun 23 | SEC ↗ |
Related companies
Savara Inc is in the Healthcare sector.